ENANTA PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 55.00K shares.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 5.00K shares.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 16.00K shares, a 45.45% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 5.00K shares, a 28.57% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 16.00K shares, a 0.00% change from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 16.00K shares, a 87.10% decline from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 124.00K shares, a 76.02% decline from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 517.00K shares, a 300.78% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 55.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | 81.00K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | 26.00K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 16.00K shares 10-Q · filed 2026-02-11 | 21.00K shares derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-09-30 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | 16.00K shares 10-K · filed 2025-11-19 |
| 2025-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | 18.00K shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | 21.00K shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | 11.00K shares 10-Q · filed 2025-02-12 | 27.00K shares derived: sum of 4 quarters · filed 2025-02-12 |
| 2024-09-30 | 7.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | 16.00K shares 10-K · filed 2024-11-27 |
| 2024-06-30 | 3.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | |
| 2024-03-31 | 6.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | |
| 2023-12-31 | 0.00 shares 10-Q · filed 2024-02-08 | |
| 2023-09-30 | 124.00K shares 10-K · filed 2023-11-22 | |
| 2023-03-31 | 68.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 296.00K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | 56.00K shares 10-Q · filed 2023-02-08 | 325.00K shares derived: sum of 4 quarters · filed 2023-02-08 |
| 2022-09-30 | 70.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | 517.00K shares 10-K · filed 2022-11-23 |
| 2022-06-30 | 102.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | 474.00K shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 97.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09 | 398.00K shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 248.00K shares 10-Q · filed 2022-02-10 | 344.00K shares derived: sum of 4 quarters · filed 2022-02-10 |
| 2021-09-30 | 27.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | 129.00K shares 10-K · filed 2021-11-24 |
| 2021-06-30 | 26.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 | 109.00K shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 43.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10 | 166.00K shares derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | 33.00K shares 10-Q · filed 2021-02-09 | 284.00K shares derived: sum of 4 quarters · filed 2021-02-09 |
| 2020-09-30 | 7.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | 327.00K shares 10-K · filed 2020-11-25 |
| 2020-06-30 | 83.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10 | 342.00K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 161.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11 | 271.00K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 76.00K shares 10-Q · filed 2020-02-10 | 267.00K shares derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-09-30 | 22.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | 231.00K shares 10-K · filed 2019-11-27 |
| 2019-06-30 | 12.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | 244.00K shares derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | 157.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | 332.00K shares derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | 40.00K shares 10-Q · filed 2019-02-08 | 240.00K shares derived: sum of 4 quarters · filed 2019-02-08 |
| 2018-09-30 | 35.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | 229.00K shares 10-K · filed 2018-11-29 |
| 2018-06-30 | 100.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | 224.21K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 65.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | 160.14K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 29.00K shares 10-Q · filed 2018-02-09 | 96.64K shares derived: sum of 4 quarters · filed 2018-02-09 |
| 2017-09-30 | 30.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | 72.00K shares 10-K · filed 2017-12-11 |
| 2017-06-30 | 35.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | 41.94K shares derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | 1.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | 85.17K shares derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | 4.36K shares 10-Q · filed 2017-02-09 | 245.15K shares derived: sum of 4 quarters · filed 2017-02-09 |
| 2016-09-30 | 147.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | 319.08K shares 10-K · filed 2016-12-09 |
| 2016-06-30 | 79.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | 327.83K shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 161.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | 266.21K shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 78.28K shares 10-Q · filed 2016-02-09 | 181.88K shares derived: sum of 4 quarters · filed 2016-02-09 |
| 2015-09-30 | 8.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | 122.26K shares 10-K · filed 2015-12-11 |
| 2015-06-30 | 17.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | 127.21K shares derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | 77.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | 212.24K shares derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | 18.66K shares 10-Q · filed 2015-02-06 | 647.30K shares derived: sum of 4 quarters · filed 2015-02-06 |
| 2014-09-30 | 13.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | 664.79K shares 10-K · filed 2014-12-11 |
| 2014-06-30 | 102.56K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | 754.66K shares derived: sum of 4 quarters · filed 2014-08-12 |
| 2014-03-31 | 512.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | 659.36K shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 36.15K shares 10-Q · filed 2014-02-13 | |
| 2013-09-30 | 103.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-18 | 538.58K shares 10-K · filed 2013-12-18 |
| 2013-06-30 | 7.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |